ImmunityBio (26CA.STU) Q3 2026 Earnings

12AugConfirmed
Q2 2026
Next
-0.53
-0.37
-0.22
-0.06

Details

Expected EPS
-0.07489762139999999
Actual EPS
N/A
Surprise EPS
0.07
Surprise Percent
+100%

Description

ImmunityBio (26CA.STU) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts